TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06183255

Intervention type: OTHER
Intervention: Observation and evaluation of clinical parameters in the two cohorts
Description: During medical history evaluation, all factors that could negatively affect male fertility, like prevalent comorbidities, previous testis surgery, and any disorder affecting testicular function will be investigated in fertile and infertile men. Moreover, family history will be deeply investigated, including fertility status and prevalence of malignant Non Communicables Diseases. A comprehensive physical examination will be performed on each infertile and fertile man.

Intervention type: OTHER
Intervention: Observation and evaluation of clinical parameters in the two cohorts
Description: During medical history evaluation, all factors that could negatively affect male fertility, like prevalent comorbidities, previous testis surgery, and any disorder affecting testicular function will be investigated in fertile and infertile men. Moreover, family history will be deeply investigated, including fertility status and prevalence of malignant Non Communicables Diseases. A comprehensive physical examination will be performed on each infertile and fertile man.
Study: NCT05387863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) Web Tool
Description: The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Institutional Pamphlet
Description: The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.
Study: NCT04329598

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation Group
Description: Whole-Body Electromyostimulation group includes exercises with electric stimulation. Whole-Body Electromyostimulation group will have 45 minutes of exercises which are specific exercises for Lumbar Disc Herniation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Group
Description: Exercise group includes exercises without electric stimulation. Exercise group will have 45 minutes of exercises which are specific exercises for Lumbar Disc Herniation.
Study: NCT06180681

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Team-Enhanced Collaborative Life Skills Program
Description: We will integrate three team-based implementation strategies to enhance team effectiveness in CLS, including Team Charters, Team Communication Training via Student Handoff Protocols, and Team Performance Monitoring. These interventions have been shown to improve cognitive (e.g., shared mental models) and affective ((e.g., trust, collective efficacy) team-based emergent states and enhance team-based processes, such as communication and coordination.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Collaborative Life Skills Program
Description: CLS is a school-delivered intervention coordinating three empirically-supported approaches: teacher consultation and a daily behavior report card, behavioral parent training and child skills training. The three components are integrated over a 10-12 week period to improve symptoms and functional impairment among youth with ADHD.
Study: NCT06203860

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cardio-Metabolic Clinic
Description: The Cardio-Metabolic Clinic will adhere to a standardized evaluation and treatment program based on the latest treatment guidelines from the European Cardiovascular Society. The assessment will include the following points:~* Lipid management~* Blood pressure management~* Antithrombotic therapy~* Glycemic targets~* Prevention of diabetes-related complications~* Treatment of vascular disease affecting the lower extremities~* Evaluation of cardioprotective drugs~* Counseling on lifestyle factors, including diet, smoking, alcohol, and exercise~* Guidance on vaccinations
Study: NCT06497920

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS to the motor cortex
Description: Active bilateral repetitive transcranial magnetic stimulation to the motor cortex

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS to the motor cortex
Description: Sham bilateral repetitive transcranial magnetic stimulation to the motor cortex
Study: NCT05519852

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates training
Description: the pilates group (20 patients) will be trained 30 minutes of pilates exercise (before it there will be warm up period and after it there will be cooldown period , each will be 5 minutes). the pilates will be repeated five sessions per the week for 3 months
Study: NCT05234424

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: THRIVE
Description: During general anesthesia, apneic oxygenation with a high flow nasal oxygen system is applied for 10 minutes. Video laryngoscopy will be performed to achieve similar airway patency.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: THRIVE
Description: During general anesthesia, apneic oxygenation with a high flow nasal oxygen system is applied for 10 minutes. Video laryngoscopy will be performed to achieve similar airway patency.
Study: NCT05105841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Oral Capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Intravenous (IV) Infusion
Study: NCT05348499

Intervention type: OTHER
Intervention: Questionnaire/Interview
Description: Questionnaire/Interview

Intervention type: OTHER
Intervention: Questionnaire/Interview
Description: Questionnaire/Interview
Study: NCT04691011

Intervention type: OTHER
Group type: OTHER
Intervention: Muscular MRI
Description: MRI (1.5T)

Intervention type: OTHER
Group type: OTHER
Intervention: Muscular MRI
Description: MRI (1.5T)

Intervention type: OTHER
Group type: OTHER
Intervention: Muscular MRI
Description: MRI (1.5T)

Intervention type: OTHER
Group type: OTHER
Intervention: Electrophysiological exam
Description: MUNIX

Intervention type: OTHER
Group type: OTHER
Intervention: Electrophysiological exam
Description: MUNIX

Intervention type: OTHER
Group type: OTHER
Intervention: Electrophysiological exam
Description: MUNIX

Intervention type: OTHER
Group type: OTHER
Intervention: Brain MRI
Description: MRI (7T)

Intervention type: OTHER
Group type: OTHER
Intervention: Spinal cord MRI
Description: 7T and 3T MRI
Study: NCT06183060

Intervention type: PROCEDURE
Intervention: endotracheal intubation
Description: all patients will receive laryngoscopy and endotracheal intubation

Intervention type: PROCEDURE
Intervention: endotracheal intubation
Description: all patients will receive laryngoscopy and endotracheal intubation
Study: NCT05807776

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200mg, iv, d1, Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200mg, iv, d1, Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, Lenvatinib
Description: Tislelizumab combined with lenvatinib:~Tislelizumab 200mg, iv, d1, Q3W Lenvatinib 8mg，po，qd.
Study: NCT06238349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral bifidobacterium triple live powder
Description: The newborns in the Bifidobacterium group will receive all interventions prescribed for the control group, and also were assigned to orally be given Bifidobacterium triple viable powder (Shanghai Xinyi Pharmaceutical Company, Peifeikang powder, 0.5 g/dose, 3 times/day. Bifidobacterium triple viable powder contains live bacteria of long Bifidobacterium at no less than 1.0 × 107 CFU/g, stored at 2.8℃ away from light) beginning within 24 hours after birth and continuing for 1 week. No sunbathing will be prescribed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunbathing
Description: The sunbathing group will receive all interventions prescribed for the control group and be assigned to sunbathing (placement in a bed next to a sunny window) after birth for one week according to the following plan: Every morning and afternoon neonates sunbath for 0.5 to 1 hour to avoid excess sun exposure. Healthcare workers will guide and assist families in their preparations. The caregiver will place a black eye patch on the infants to protect the retina, and a cloth will be wrapped around the hands and feet to prevent scratching, but care will be taken that the wrap is not too tight to avoid circulation disorders. Baby boys will have their genitals covered to protect them from sun damage. After feeding, the newborn will be placed on a sunny platform with fully exposed skin and frequent position changes, while the glass of the window prevent injury from UV light exposure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunbathing and the Oral bifidobacterium triple live powder
Description: The combination group will receive all interventions of both the group sunbathing and the Bifidobacterium group as well as all interventions prescribed for the control group.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional treatment
Description: Conventional treatment: Neonates will be placed in an incubator (Ningbo David Medical Device Co., LTD, XHZ model) at 30℃ and relative humidity at 55%. Throughout the study, exclusive breastfeeding and professional care will be provided for the newborns. Newborns requiring phototherapy receive it in the following manner: Phototherapy eye masks (Foshan Forman Medical Technology Co., LTD., Yuesun Mechanical Equipment No. 20160015) and phototherapy diapers (Foshan Baojusheng Medical Equipment Co., LTD., GB/T33280) will be used to cover the eyes and perineum, respectively. Phototherapy was provided via LED blue light continuous irradiation with a wavelength of 425-475nm. All treated neonates will receive continuous phototherapy for 12 hours, then allowe to rest for 6-8 hours, then receive another 12 hours of continuous phototherapy. The decision to continue with further treatment depends on changes in the neonate's jaundice.
Study: NCT05393778

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Measured Technique
Description: Manual intra-operative checks and tools are used to aid in component placement during surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Navigated Technique
Description: IntelliJoint® navigation is an imageless-based navigation system that utilizes a miniature infrared camera and microelectronics to measure hip center of rotation, acetabular inclination and version, leg length, and offset. The device provides accurate real-time data on implant positioning to aid in placement of the components during surgery.
Study: NCT06343493

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal saline heated up to 50 °C
Description: Saline heated up to 50 °C used for irrigation
Study: NCT05302882

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Myofascial release
Description: The physiotherapist placed both palms on the two right and left ribs at the T12 level and applied continuous stretching to the superior for 2 minutes. After this application, the physiotherapist placed one hand on the sacrum with the other hand on T12 with his hands crossed, and applied rhythmically 2 seconds of stretching and 2 seconds of relaxation for a total of 2 minutes. Then, myofascial release was terminated by applying deep compression to the paraspinal muscles with palms for 2 minutes on the right and 2 minutes on the left side, respectively.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Classical massage
Description: Classical massage was applied to the lumbar region for 9 minutes. Classical massage was applied with the patient in the prone position. A small amount of solid vaseline was taken and a gentle stroke was applied for 1 minute to spread it sufficiently to the lumbar region. Then, superficial stroking was applied to the right paraspinal region for 1 minute from distal to proximal by the physiotherapist. After the same procedure was performed on the right paraspinal region for 1 minute. Then, both hands were placed on the right and left paraspinal region and friction was applied for 2 minutes. Afterwards, the patient's right paraspinal region was kneeding for 1 minute and then the same procedure was applied to the left paraspinal region for 1 minute. As the last procedure, the fingertips of both hands were placed on the right and left paraspinal region and the classical massage was completed by performing 2 minutes of deep euphlorage from the L5-S1 level to the T12 level.
Study: NCT06148636

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.
Study: NCT05439512

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transantral orbital floor reconstruction by titanium mesh
Description: reconstruction of orbital floor fracture by patient specific titanium mesh
Study: NCT06148636

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.
Study: NCT04854967

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rescind home oxygen order
Description: A note will be entered in the medical record describing the participants randomization into the intervention group. The note will be signed by study staff and will accompany the discontinuation of the patient's home oxygen by a study clinician.
Study: NCT06084403

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 20 ml volume adductor canal block
Description: ACB will be performed at the end of the surgery. After identifying the adductor canal, by using the in-plane technique, the probe will be placed at the mid-thigh, half the distance between the inguinal crease and the patella, for block location. The superficial femoral artery will be visualized dorsal to the sartorius muscle. Then, the probe will be removed to distally. At this level, the hyperechoic view of the saphenous nerve will be visualized lateral and anterior to the artery in the subsartorial region. 5 mL of saline will be injected to confirm the proper injection site, and then a dose of 0.25% bupivacaine (Buvasin %5 flakon) 20ml will be injected here.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 30 ml volume adductor canal block
Description: ACB will be performed at the end of the surgery. After identifying the adductor canal, by using the in-plane technique, the probe will be placed at the mid-thigh, half the distance between the inguinal crease and the patella, for block location. The superficial femoral artery will be visualized dorsal to the sartorius muscle. Then, the probe will be removed to distally. At this level, the hyperechoic view of the saphenous nerve will be visualized lateral and anterior to the artery in the subsartorial region. 5 mL of saline will be injected to confirm the proper injection site, and then a dose of 0.25% bupivacaine(Buvasin %5 flakon) 30ml will be injected here.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 40 ml volume adductor canal block
Description: ACB will be performed at the end of the surgery. After identifying the adductor canal, by using the in-plane technique, the probe will be placed at the mid-thigh, half the distance between the inguinal crease and the patella, for block location. The superficial femoral artery will be visualized dorsal to the sartorius muscle. Then, the probe will be removed to distally. At this level, the hyperechoic view of the saphenous nerve will be visualized lateral and anterior to the artery in the subsartorial region. 5 mL of saline will be injected to confirm the proper injection site, and then a dose of 0.25% bupivacaine(Buvasin %5 flakon) 40ml will be injected here.
Study: NCT05558163

Intervention type: PROCEDURE
Group type: OTHER
Intervention: transverse scrotal approach for PPI
Description: penile prothesis implantation through penoscrotal approach outcome
Study: NCT04854967

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provider Education
Description: A note will be entered in the medical record informing the patient's individual medical providers (i.e. primary care provider, pulmonologist) of their randomization into the intervention group. The note will include the evidence-base for oxygen use among patients with COPD.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Education
Description: The patient will receive a patient education page about discontinuation of home oxygen after recovery from a hospitalization that was developed by Consumer Reports in conjunction with the Choosing Wisely Campaign.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teach-to-goal inhaler training
Description: Teach-to-goal (TTG) inhaler training is a patient-centered education strategy that has been shown to decrease inhaler misuse and decrease acute care utilization. The training is tailored to the patient and meets guideline recommendations for assessment and instruction of inhaler technique. The rounds of assessment and demonstration can be completed until acceptable skill level is attained and tailored to the specific medication prescribed.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pursed lip breathing
Description: Pursed lip-breathing will be taught to the participants randomized to the intervention arm. This simple technique relieves breathlessness and has been shown to improve functional capacity in patients with COPD. Participants will be given an instructional handout to refer to after the visit.
Study: NCT05558163

Intervention type: PROCEDURE
Group type: OTHER
Intervention: penoscrotal approach for PPI
Description: penile prothesis implantation through penoscrotal approach outcome
Study: NCT05286307

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPACK block
Description: IPACK block with 20 mL of 0.25% Bupivacaine injected into the Interspace between the Popliteal Artery and Capsule of the Knee
Study: NCT06148636

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.
Study: NCT05546957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Administered orally once per day (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Administered orally once per day (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Administered orally once per day (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rivaroxaban low dose
Description: Administered orally twice per day (BID)